Taro Pharmaceutical Industries has received the FDA's approval of its abbreviated new drug application for fluorouracil topical cream USP, 5%, fluorouracil Read More >>

Taro Pharmaceutical Industries Ltd. (Pink Sheets: TAROF) today reported that it received approval from the US Food and D Read More >>

Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company," Pink Sheets: TAROF) today reported that it received approval from the U.S. Read More >>

Valeant Pharmaceuticals International (NYSE:VRX) is one of today's best performing stocks, up 1.7% to $38.62. The S&P is currently Read More >>

Valeant Pharmaceuticals International, a specialty pharmaceutical company, has entered into an agreement with Spear Pharmaceuticals, Read More >>

Valeant Pharmaceuticals International (NYSE: VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive o Read More >>

Valeant Pharmaceuticals International, a multinational specialty pharmaceutical company, has entered into an agreement with Spear Pharmaceuticals, for right Read More >>

Valeant Pharmaceuticals International (NYSE: VRX), today announced that it has entered into an agreement with Spear Pharmaceuticals, In Read More >>

SmarTrend identified an Uptrend for Valeant Pharmaceuticals International (NYSE:VRX) on January 13, 2010 at $34.66. In approximately 1 month, Val Read More >>

Valeant Pharmaceuticals International, a specialty pharmaceutical company, has reported a net income of $162.41 million, or $1.96 per diluted share, for the Read More >>

Valeant Pharmaceuticals International (VRX)

Expected next earnings release:

Announcement date: 2/22/2010 - Before Market

Earnings Qu
          
            Read More
            >>
          
        

Valeant Pharmaceuticals International (NYSE: VRX) said it continues to expect 2010 earnings of $2.45 to $2.70 per share. The current Read More >>

Valeant Pharmaceuticals International (NYSE: VRX) today announced fourth quarter and full year financial results for 2009.

"Acr Read More >>

(Comment on this article at http://www.financialwire.net/2010/02/22/conference-calls-today-10-1030-a-m-est-12/)

February 22, 2010 (FinancialWire) Read More >>

SmarTrend identified an Uptrend for Valeant Pharmaceuticals International (NYSE:VRX) on January 13, 2010 at $34.67. In approximately 1 month, Val Read More >>

Valeant Pharmaceuticals International (VRX)

Expected next earnings release:

Announcement date: 2/22/2010 - Before Market

Earnings Qu
          
            Read More
            >>
          
        

Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call and a live Internet webcast along Read More >>

Valeant Pharmaceuticals International (VRX)

Expected next earnings release:

Announcement date: 2/24/2010 - Before Market

Earnings Qu
          
            Read More
            >>
          
        

SmarTrend's candlestick pattern scanner has detected a bullish engulfing pattern for shares of Valeant Pharmaceuticals International (N Read More >>

SmarTrend's candlestick pattern scanner has detected a bullish harami candle pattern for shares of Valeant Pharmaceuticals Internationa Read More >>

Valeant Pharmaceuticals International (NYSE: VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive o Read More >>

Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call and a live Internet webc Read More >>